Physician network position and patient outcomes following implantable cardioverter defibrillator therapy

被引:8
|
作者
Moen, Erika L. [1 ,2 ]
Bynum, Julie P. [3 ]
Skinner, Jonathan S. [4 ,5 ]
O'Malley, Alistair J. [1 ,2 ]
机构
[1] Geisel Sch Med Dartmouth, Dept Biomed Data Sci, Lebanon, NH 03756 USA
[2] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03756 USA
[3] Univ Michigan, Dept Internal Med, Ann Arbor, MI USA
[4] Dept Econ, Hanover, NH USA
[5] Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA
关键词
case fatality; degree centrality; implantable cardioverter defibrillator; physician network; OPERATIVE MORTALITY; HOSPITAL VOLUME; SHARING NETWORKS; SEX-DIFFERENCES; SURGEON VOLUME; COMPLICATIONS;
D O I
10.1111/1475-6773.13151
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective To evaluate two novel measures of physician network centrality and their associations with implantable cardioverter defibrillator (ICD) procedure volume and health outcomes. Data Sources Medicare claims and the National Cardiovascular Data Registry data from 2007 to 2011. Study Design We constructed a national cardiovascular disease patient-sharing physician network and used network analysis to characterize physician network centrality with two measures: within-hospital degree centrality (number of connections within a hospital) and across-hospital degree centrality (number of connections across hospitals). The primary outcome was risk-adjusted 2-year case fatality. Hierarchical logistic regression estimated the effects of physician's within-hospital and across-hospital degree centrality on case fatality. We included 105 109 ICD therapy patients and 3474 ICD implanting physicians in our analyses. Principal Findings After controlling for other physician and hospital characteristics, we observed greater risk-adjusted case fatality among patients treated by physicians in the highest across-hospital degree tertile compared to lowest tertile (OR [95% CI] = 1.10 [1.04-1.16], P = 0.001) and lowest tertile volume physicians compared with highest volume (OR [95% CI] = 0.90 [0.84-0.95], P < 0.001). Physician's within-hospital degree tertile was inversely associated with case fatality but not statistically significant. Conclusions Degree centrality measures capture information independent of procedure volume and raise questions about the quality of physicians with networks that predict worse health outcomes.
引用
收藏
页码:880 / 889
页数:10
相关论文
共 50 条
  • [1] Assessing Variation in Implantable Cardioverter Defibrillator Therapy Guideline Adherence With Physician and Hospital Patient-sharing Networks
    Moen, Erika L.
    Bynum, Julie P.
    Austin, Andrea M.
    Skinner, Jonathan S.
    Chakraborti, Gouri
    O'Malley, Alistair James
    MEDICAL CARE, 2018, 56 (04) : 350 - 357
  • [2] Reel syndrome in a patient with an implantable cardioverter-defibrillator
    Cruz Cardentey, Marleny
    Castro Hevia, C. Jesus A.
    Castaneda Chirino, Osmin
    Falcon Rodriguez, Roywi
    Lopez Martinez, Frank
    CORSALUD, 2018, 10 (03): : 252 - 255
  • [3] Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator
    Curtis, Jeptha P.
    Luebbert, Jeffrey J.
    Wang, Yongfei
    Rathore, Saif S.
    Chen, Jersey
    Heidenreich, Paul A.
    Hammill, Stephen C.
    Lampert, Rachel I.
    Krumholz, Harlan M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (16): : 1661 - 1670
  • [4] Implantable cardioverter defibrillator therapy in postinfarction patients
    Zareba, W
    CURRENT OPINION IN CARDIOLOGY, 2004, 19 (06) : 619 - 624
  • [5] Lost in Translation Examining Patient and Physician Perceptions of Implantable Cardioverter-Defibrillator Deactivation Discussions
    Mitar, Michael
    Alba, Ana C.
    MacIver, Jane
    Ross, Heather
    CIRCULATION-HEART FAILURE, 2012, 5 (05) : 660 - 666
  • [6] Effect of posture on position of subcutaneous implantable cardioverter-defibrillator
    Pepplinkhuizen, Shari
    Spijkerboer, Anje M.
    van der Stuijt, Willeke
    de Veld, Jolien A.
    Dijkshoorn, Leonard A.
    Stenchlak, Zosja E.
    Reijerink, Marlin A. A.
    de Weger, Anouk
    Smeding, Lonneke
    Nordkamp, Louise R. A. Olde
    Wilde, Arthur A. M.
    Knops, Reinoud E.
    HEART RHYTHM, 2025, 22 (02) : 388 - 393
  • [7] Outcomes following implantable cardioverter-defibrillator generator replacement in adults: A systematic review
    McCarthy, Killian J.
    Locke, Andrew H.
    Coletti, Margo
    Young, Diane
    Merchant, Faisal M.
    Kramer, Daniel B.
    HEART RHYTHM, 2020, 17 (06) : 1036 - 1042
  • [8] Cardiac resynchronization and implantable cardioverter defibrillator therapy:: Preliminary results from the InSync Implantable Cardioverter Defibrillator Italian Registry
    Gasparini, M
    Lunati, M
    Bocchiardo, M
    Mantica, M
    Gronda, E
    Frigerio, M
    Caponi, D
    Carboni, A
    Boriani, G
    Zanotto, G
    Ravazzi, PA
    Curnis, A
    Puglisi, A
    Klersy, C
    Vicini, I
    Cavaglià, S
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (01): : 148 - 151
  • [9] Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy
    G. H. van Welsenes
    C. J. W. Borleffs
    J. B. van Rees
    J. Z. Atary
    J. Thijssen
    E. E. van der Wall
    M. J. Schalij
    Netherlands Heart Journal, 2011, 19 : 24 - 30
  • [10] Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis
    Schuller, Joseph L.
    Zipse, Matthew
    Crawford, Thomas
    Bogun, Frank
    Beshai, John
    Patel, Amit R.
    Sweiss, Nadera J.
    Nguyen, Duy T.
    Aleong, Ryan G.
    Varosy, Paul D.
    Weinberger, Howard D.
    Sauer, William H.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2012, 23 (09) : 925 - 929